InBrace, an Irvine, California-based AI-powered orthodontics startup, closed an oversubscribed $102 million Series D round co-led by Farallon Capital Management, L.L.C., and Marshall Wace.
Additional new investors included funds and accounts managed by BlackRock, Endeavour Vision, MVM Partners, RTW Investments, LP, and Soleus Capital as well as funds affiliated with existing investors Vivo Capital, Novo Ventures, and venBio.
Company: Swift Health Systems Inc.
Round: Series D
Funding Month: September 2021
Lead Investors: Farallon Capital Management, L.L.C., and Marshall Wace
Additional Investors: BlackRock, Endeavour Vision, MVM Partners, RTW Investments, LP, Soleus Capital Vivo Capital, Novo Ventures and venBio
Company Website: https://inbrace.com/
Software Category: Teeth-straightening system-AI-powered
About the Company: InBrace was invented & founded by Drs. John Pham and Hongsheng Tong, who set out to find a healthier and more efficient teeth-straightening system for children with cleft lip and palate; partnered with USC & Children's Hospital Los Angeles. InBrace filed the first application patent of its extensive patent portfolio in 2012. InBrace is teeth straightening on autopilot with a personalized Smartwire hidden behind teeth that gently perfect smiles. InBrace treats all types of orthodontic cases from mild to severe malocclusions. InBrace is the first to introduce the use of the revolutionary Programmed Non-Sliding Mechanics process for moving teeth. Its proprietary Smartwire™ has been designed and fabricated with AI and Gentleforce™ Technology to deliver a superior experience that provides fast results and healthy tooth movement while being completely hidden behind the teeth.